Company · MED
MEDIFAST INC
Nasdaq's symbol directory lists MED on the New York Stock Exchange as “MEDIFAST INC Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 6 occasions ($1.5M); insiders sold on 2 occasions ($226K); 2 planned-sale notices; 4 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Parsa Kiai bought $1.5M
- Chard Daniel R sold $226K
Every trade (8)
- BUYParsa Kiai bought $9K
- BUYParsa Kiai bought $68K
- SELLChard Daniel R sold $112K
- SELLChard Daniel R sold $114K
- BUYParsa Kiai bought $529K
- BUYParsa Kiai bought $52K
- BUYParsa Kiai bought $501K
- BUYParsa Kiai bought $342K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Chard Daniel R $112K
- Chard Daniel R $114K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Steamboat Capital Partners, LLC 7.1%
- Susquehanna Portfolio Strategies, LLC 5.3%
- Citadel Securities GP LLC 2.6%
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3.6%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Oct 26, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.